Drupal.behaviors.print = function(context) {window.print();window.close();}>

Abbott's Q4 Molecular Dx Sales Rise 21 Percent

January 26, 2011

Abbott's Q4 Molecular Dx Sales Rise 21 Percent

The firm's US MDx sales rose 32 percent for the quarter and 27 percent for the year. Abbott also announced a restructuring for its pharma business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories